Iressa 2nd Line Phase III Study in Japan

Exclusion Criteria

• •You have received treatment for non-small lung cancer within 4 weeks before your participation in this study (except for specific therapies)
• •You have or had any disease of acute lung injury, idiopathic pulmonary fibrosis, pulmonary pneumonia, or pneumoconiosis evident on the X-ray
• •You have or had any disease of radiation pneumonia or drug-induced pneumonia, which requires treatment with corticosteroids